Gyre Therapeutics (GYRE) Operating Leases (2019 - 2026)
Gyre Therapeutics (GYRE) reported Operating Leases of $72000.0 for Q1 2026, down 90.77% year-over-year from $780000.0 in Q1 2025, and down 76.24% on a QoQ basis from $303000.0 in Q4 2025.
Gyre Therapeutics (GYRE) has 8 years of Operating Leases data on file, last reported at $72000.0 in Q1 2026.
- Quarterly Operating Leases fell 90.77% year-over-year to $72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72000.0 (down 90.77% YoY) and the FY2025 annual result came in at $303000.0, down 65.76% from the prior year.
- Operating Leases retreated to $72000.0 in Q1 2026 per GYRE's latest filing, from $303000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.3 million in Q2 2024 and bottomed at $72000.0 in Q1 2026.
- The 5-year median for Operating Leases is $539000.0 (2025), against an average of $567545.5.
- The widest annual swing landed in 2025, when Operating Leases jumped 345.71%; it then tumbled 90.77% in 2026.
- Tracing GYRE's Operating Leases over 5 years: stood at $121000.0 in 2022, then jumped by 64.46% to $199000.0 in 2023, then soared by 344.72% to $885000.0 in 2024, then sank by 65.76% to $303000.0 in 2025, then sank by 76.24% to $72000.0 in 2026.
- Per Business Quant, the three latest GYRE Operating Leases figures stand at $72000.0 (Q1 2026), $303000.0 (Q4 2025), and $539000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 780,000.00 |
| Dec 31, 2024 | 885,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Dec 31, 2021 | 408,000.00 |
| Sep 30, 2021 | 550,000.00 |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 806,000.00 |
| Dec 31, 2020 | 981,000.00 |
| Sep 30, 2020 | 925,000.00 |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 1.19 Mn |
| Dec 31, 2019 | 1.32 Mn |
| Sep 30, 2019 | 1.44 Mn |
| Jun 30, 2019 | 1.57 Mn |
| Mar 31, 2019 | 1.69 Mn |